Page last updated: 2024-10-21

n-methyl-3,4-methylenedioxyamphetamine and Atrial Fibrillation

n-methyl-3,4-methylenedioxyamphetamine has been researched along with Atrial Fibrillation in 2 studies

N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.

Atrial Fibrillation: Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Neumann, J1
Azatsian, K1
Höhm, C1
Hofmann, B1
Gergs, U1
Madhok, A1
Boxer, R1
Chowdhury, D1

Other Studies

2 other studies available for n-methyl-3,4-methylenedioxyamphetamine and Atrial Fibrillation

ArticleYear
Cardiac effects of ephedrine, norephedrine, mescaline, and 3,4-methylenedioxymethamphetamine (MDMA) in mouse and human atrial preparations.
    Naunyn-Schmiedeberg's archives of pharmacology, 2023, Volume: 396, Issue:2

    Topics: Animals; Atrial Fibrillation; Ephedrine; Hallucinogens; Heart Atria; Humans; Mescaline; Mice; Myocar

2023
Atrial fibrillation in an adolescent--the agony of ecstasy.
    Pediatric emergency care, 2003, Volume: 19, Issue:5

    Topics: Adolescent; Alcohol Drinking; Atrial Fibrillation; Diagnosis, Differential; Emergencies; Humans; Mal

2003